Company Filing History:
Years Active: 1998-1999
Title: Yasuo Ohhata: Innovator in Thiazolidinone Derivatives
Introduction
Yasuo Ohhata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thiazolidinone derivatives. With a total of 2 patents to his name, his work has implications for treating angina pectoris.
Latest Patents
Ohhata's latest patents include an optically active thiazolidinone derivative. This compound is characterized by a general formula that allows for various substitutions, making it versatile in its applications. The derivative exhibits excellent anti-angina pectoris action, proving useful as both a preventive and therapeutic agent for angina pectoris. Another patent focuses on thiazolidinone compounds and compositions for angina pectoris, which also demonstrate significant anti-anginal effects.
Career Highlights
Yasuo Ohhata is currently associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His research has led to advancements that could improve the quality of life for patients suffering from heart conditions.
Collaborations
Ohhata has collaborated with notable colleagues such as Sadao Ishihara and Fujio Saito. Their combined expertise has contributed to the successful development of his patented compounds.
Conclusion
Yasuo Ohhata's work in thiazolidinone derivatives showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against angina pectoris, highlighting the importance of innovation in healthcare.